Hudson Bay Capital Management’s CAMP4 Therapeutics CAMP Stock Holding History

Hudson Bay Capital Management’s Portfolio CAMP Stock Details CAMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$214K	Buy	+48,511	New	+$230K	﹤0.01%	1087

Other funds holding CAMP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $437M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Hudson Bay Capital Management's CAMP Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in CAMP4 Therapeutics (CAMP) in Q1 2026: 48,511 shares worth $214K. The stake represents ﹤0.01% of the portfolio and ranks #1087 among its holdings.

46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

Hudson Bay Capital Management held 48,511 shares of CAMP4 Therapeutics worth $214K as of Q1 2026.
CAMP4 Therapeutics was a new Hudson Bay Capital Management position in Q1 2026.
CAMP4 Therapeutics made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1087 holding.
46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.